(Q24300340)

English

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression

scientific article

In more languages

Statements

scholarly article

0 references

Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression (English)

0 references

Transforming growth factor beta receptor 3

1 reference

GOA release 2020-03-11

Transforming growth factor beta 2

1 reference

GOA release 2020-03-11

transforming growth factor beta 1

1 reference

GOA release 2020-03-11

pancreatic cancer

1 reference

based on heuristic

inferred from title

neoplastic invasiveness

1 reference

based on heuristic

inferred from title

Elizabeth M Chislock

object named as

Elizabeth M Chislock

3

0 references

5

object named as

Gerard C Blobe

0 references

author name string

Kelly J Gordon

1

0 references

Mei Dong

2

0 references

Timothy A Fields

4

0 references

language of work or name

0 references

publication date

February 2008

0 references

0 references

29

0 references

252-62

0 references

2

0 references

Pancreatic cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

TGF-beta and epithelial-to-mesenchymal transitions

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Role of transforming growth factor beta in human disease

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

The logic of TGFbeta signaling.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Functional role of transforming growth factor-beta type III receptor during palatal fusion

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

The type III TGF-beta receptor suppresses breast cancer progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Loss of betaglycan expression in ovarian cancer: role in motility and invasion

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Genetic alterations in pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Expression of betaglycan in pregnant tIssues throughout gestation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

ONCOMINE: a cancer microarray database and integrated data-mining platform

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Identification of soluble transforming growth factor-beta receptor III (sTbetaIII) in rat milk

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Betaglycan presents ligand to the TGF beta signaling receptor.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Pancreatic cancer biology and genetics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Modulation of NFkappaB activity and E-cadherin by the type III transforming growth factor beta receptor regulates cell growth and motility

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Molecular pathology of pancreatic cancer: in quest of tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Karyotypic abnormalities in tumours of the pancreas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

21 January 2018

High-resolution deletion mapping of chromosome arm 1p in pancreatic cancer identifies a major consensus region at 1p35

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGM249

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1093/CARCIN/BGM249

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24300340&oldid=1992327856"